ArticleInvestigational new drugs2012

Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies.

Maarten J Deenen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.